Author

S Goyal

Observed name: Sohal V Goyal

Observed institution: McMaster University

OpenAlex ID: A5109674915

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

AMMI Canada Practice Point: Updated recommendations for treatment of adults with symptomatic COVID-19 in 2023–2024

2023 · Jennifer M Grant, John Lam, et al. · Journal of the Association of Medical Microbiology and Infectious Disease Canada · 4

Covid-19: an analysis of an extended SEIR model and a comparison of different intervention strategies

2020 · Arghya Das, Anjan Dhar, et al. · Europe PMC (PubMed Central) · 2

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

Works count: 8

Citation count: 98

H-index: 4

I10-index: 3